Bavarian Nordic A/S (BVNRY)
7.331
-0.11
(-1.49%)
USD |
OTCM |
Jun 25, 16:00
Bavarian Nordic Price to Book Value: 1.165 for June 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
June 25, 2024 | 1.165 |
June 24, 2024 | 1.182 |
June 21, 2024 | 1.168 |
June 20, 2024 | 1.203 |
June 18, 2024 | 1.203 |
June 17, 2024 | 1.200 |
June 14, 2024 | 1.223 |
June 13, 2024 | 1.26 |
June 12, 2024 | 1.312 |
June 11, 2024 | 1.309 |
June 10, 2024 | 1.354 |
June 07, 2024 | 1.378 |
June 06, 2024 | 1.420 |
June 05, 2024 | 1.428 |
June 04, 2024 | 1.401 |
June 03, 2024 | 1.417 |
May 31, 2024 | 1.419 |
May 30, 2024 | 1.356 |
May 29, 2024 | 1.340 |
May 28, 2024 | 1.354 |
May 24, 2024 | 1.375 |
May 23, 2024 | 1.354 |
May 22, 2024 | 1.363 |
May 21, 2024 | 1.328 |
May 20, 2024 | 1.363 |
Date | Value |
---|---|
May 17, 2024 | 1.374 |
May 16, 2024 | 1.331 |
May 15, 2024 | 1.313 |
May 14, 2024 | 1.277 |
May 13, 2024 | 1.262 |
May 10, 2024 | 1.227 |
May 09, 2024 | 1.218 |
May 08, 2024 | 1.234 |
May 07, 2024 | 1.230 |
May 06, 2024 | 1.220 |
May 03, 2024 | 1.184 |
May 02, 2024 | 1.146 |
May 01, 2024 | 1.146 |
April 30, 2024 | 1.151 |
April 29, 2024 | 1.152 |
April 26, 2024 | 1.120 |
April 25, 2024 | 1.099 |
April 24, 2024 | 1.136 |
April 23, 2024 | 1.136 |
April 22, 2024 | 1.130 |
April 19, 2024 | 1.105 |
April 18, 2024 | 1.099 |
April 17, 2024 | 1.118 |
April 16, 2024 | 1.134 |
April 15, 2024 | 1.151 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.066
Minimum
Oct 25 2023
5.369
Maximum
Feb 20 2020
2.399
Average
2.289
Median
Price to Book Value Benchmarks
Genmab A/S | 3.488 |
Ascendis Pharma A/S | -- |
Galecto Inc | 0.4729 |
Evaxion Biotech AS | 2.728 |
IO Biotech Inc | 0.7189 |
Price to Book Value Related Metrics
PE Ratio | 11.79 |
PS Ratio | 1.747 |
PEG Ratio | 0.053 |
Price to Free Cash Flow | 11.32 |
Price | 7.331 |
Earnings Yield | 8.48% |
Market Cap | 1.714B |
Operating PE Ratio | 11.62 |
Normalized PE Ratio | 11.90 |